SalivaDirect, Inc.

SalivaDirect, Inc. is at the forefront of biotechnology research, dedicated to advancing accessible and equitable surveillance of respiratory pathogens. Originating from the Yale School of Public Health, SalivaDirect has evolved into a global diagnostic network committed to innovative and collaborative solutions. The organization's efforts significantly aid communities in overcoming challenges, ensuring a dynamic response to public health needs.

Located in New Haven, CT, SalivaDirect, Inc. continues to drive the use of saliva as a superior sample type. With over 200 CLIA laboratories providing more than 7 million SalivaDirect tests nationwide, the impact is substantial. Independently validated in over 15 countries, SalivaDirect demonstrates its commitment to global health and equitable diagnostic testing.

SalivaDirect, Inc. is dedicated to ongoing innovation and expansion, enhancing its capabilities to serve communities worldwide. We invite the management team at SalivaDirect to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions and advancements in biotechnology research.